Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4Maha Katabi, Shala Yuan, Helen Chan, et al.
Oncotarget|December 2, 2017
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cellsHolly C Lewis, Raghavan Chinnadurai, Steven E Bosinger, et al.
The Annals of Thoracic Surgery|January 23, 2003
Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia modelAbdulaziz Al-Khaldi, Hilal Al-Sabti, Jacques Galipeau, et al.
Journal of Multiple Sclerosis|July 3, 2015
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis PatientsJakob Habib, Jiusheng Deng, Neil Lava, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 21, 2020
Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and RemyelinationAndrea Pennati, Emily A Nylen, Ian D Duncan, et al.
Cell Reports|February 13, 2020
CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut InjuryJayeeta Giri, Rahul Das, Emily Nylen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2014
IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cellsRaghavan Chinnadurai, Ian B Copland, Seema R Patel, et al.
Blood|August 25, 2005
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient miceNicoletta Eliopoulos, John Stagg, Laurence Lejeune, et al.
Experimental Hematology|January 13, 2009
Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutationFrançois Mercier, Yury Monczak, Moïra François, et al.
Biomed Research International|December 19, 2013
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseasesRaghavan Chinnadurai, Edmund K Waller, Jacques Galipeau, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4Maha Katabi, Shala Yuan, Helen Chan, et al.
Oncotarget|December 2, 2017
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cellsHolly C Lewis, Raghavan Chinnadurai, Steven E Bosinger, et al.
The Annals of Thoracic Surgery|January 23, 2003
Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia modelAbdulaziz Al-Khaldi, Hilal Al-Sabti, Jacques Galipeau, et al.
Journal of Multiple Sclerosis|July 3, 2015
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis PatientsJakob Habib, Jiusheng Deng, Neil Lava, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 21, 2020
Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and RemyelinationAndrea Pennati, Emily A Nylen, Ian D Duncan, et al.
Cell Reports|February 13, 2020
CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut InjuryJayeeta Giri, Rahul Das, Emily Nylen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2014
IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cellsRaghavan Chinnadurai, Ian B Copland, Seema R Patel, et al.
Blood|August 25, 2005
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient miceNicoletta Eliopoulos, John Stagg, Laurence Lejeune, et al.
Experimental Hematology|January 13, 2009
Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutationFrançois Mercier, Yury Monczak, Moïra François, et al.
Biomed Research International|December 19, 2013
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseasesRaghavan Chinnadurai, Edmund K Waller, Jacques Galipeau, et al.
Pageof 20